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‘Living beneath the sword of Damocles’: Perceptions of risk and fears of cancer recurrence 
amongst Australian melanoma survivors at high and moderate risk of developing new primary 
disease. 
 
Background: Despite continued progress in the clinical management of melanoma, patients continue to 
live at increased risk of developing new primary disease. This study examined risk perceptions, fears of 
cancer recurrence, melanoma-related behaviours, and satisfaction with clinical care amongst melanoma 
survivors at high or moderate risk of new primary disease.  
 
Methods: Participants were recruited via the High Risk Clinic at the Sydney Melanoma Diagnostic 
Centre (high risk group) or the Melanoma Institute Australia (moderate risk group). Individuals at high 
risk (i.e. multiple melanoma diagnoses, or one primary melanoma and dysplastic naevus syndrome, 
DNS), or moderate risk (one melanoma and no DNS) completed a questionnaire assessing: psychological 
factors (e.g. fear of melanoma recurrence, risk perceptions, anxiety, depression); sun protection and skin 
cancer screening behaviours; satisfaction with clinical care; and demographic and clinical characteristics. 
 
Results: 310 participants completed the survey (high risk n=165; moderate risk n=145; response rate: 
79%; 56% male; mean age: 59.5 years; SD=12.8). Clinically-relevant levels of anxiety and depression, as 
measured by the HADS, were reported by 25% and 9% of participants, respectively. Seventy-three 
percent of participants reported clinically-relevant levels of fear of cancer recurrence, with mean scores 
similar between groups (t=-1.2, p=0.2). Participants reported high levels of satisfaction with melanoma 
care. Path analysis is currently underway and will be presented at the meeting.  
 
Conclusion: Melanoma patients experience a range of practical, emotional, physical, and social 
challenges as a result of their diagnosis and treatment. For some people, these challenges may continue to 
have an impact long after initial diagnosis. Although many patients exhibit healthy psychological 
adjustment, this study found that 73% of moderate- to high-risk patients report levels of fear of cancer 
recurrence indicative of the need for clinical intervention. To be efficacious, psychological support must 
be offered to patients in a timely manner, and should be tailored to the individual’s needs and resources. 
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